TrialHypertension research : official journal of the Japanese Society of Hypertension2022

Brief report on a phase I/IIa study to assess the safety, tolerability, and immune response of AGMG0201 in patients with essential hypertension.

Hironori Nakagami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.